{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T19:10:40Z","timestamp":1781032240338,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.neuroscience.2021.03.029","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T19:14:02Z","timestamp":1617736442000},"page":"143-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The Kv7 Modulator, Retigabine, is an Efficacious Antiseizure Drug for Delayed Treatment of Organophosphate-induced Status Epilepticus"],"prefix":"10.1016","volume":"463","author":[{"given":"Bryan S.","family":"Barker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3968-0608","authenticated-orcid":false,"given":"Jay","family":"Spampanato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary S.","family":"McCarren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecelia E.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Edward","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6441-8332","authenticated-orcid":false,"given":"John H.","family":"McDonough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2021.03.029_b0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.yebeh.2016.12.024","article-title":"The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication","volume":"68","author":"Althaus","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuro.2010.05.014","article-title":"Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology","volume":"31","author":"Apland","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0015","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2019.11.020","article-title":"Screening for efficacious anticonvulsants and neuroprotectants in delayed treatment models of organophosphate-induced status epilepticus","volume":"425","author":"Barker","year":"2020","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuropharm.2006.03.024","article-title":"Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures","volume":"51","author":"Boscia","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0025","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1113\/jphysiol.2007.132498","article-title":"Regulation of M(Kv7.2\/7.3) channels in neurons by PIP(2) and products of PIP(2) hydrolysis: significance for receptor-mediated inhibition","volume":"582","author":"Brown","year":"2007","journal-title":"J Physiol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0030","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1476-5381.2009.00111.x","article-title":"Neural KCNQ (Kv7) channels","volume":"156","author":"Brown","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0035","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.neuro.2012.03.011","article-title":"Organophosphate-induced brain damage: mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies","volume":"33","author":"Chen","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2042098614560736","article-title":"New antiepileptic medication linked to blue discoloration of the skin and eyes","volume":"6","author":"Clark","year":"2015","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0045","first-page":"95","article-title":"UK resilience to a chemical incident","volume":"166","author":"Clarke","year":"2019","journal-title":"J R Army Med Corps."},{"key":"10.1016\/j.neuroscience.2021.03.029_b0050","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/acschemneuro.8b00148","article-title":"Nerve agents: what they are, how they work, how to counter them","volume":"9","author":"Costanzi","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3940(95)11783-S","article-title":"Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response","volume":"195","author":"Dailey","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1528-1157.43.s.5.39.x","article-title":"Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat","volume":"43","author":"Ebert","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0065","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004691-199204010-00007","article-title":"Subcortical structures and pathways involved in convulsive seizure generation","volume":"9","author":"Gale","year":"1992","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0070","doi-asserted-by":"crossref","first-page":"114963","DOI":"10.1016\/j.taap.2020.114963","article-title":"Efficacy of retigabine in ameliorating the brain insult following sarin exposure in the rat","volume":"395","author":"Gore","year":"2020","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1535759719844750","article-title":"The roof is leaking and a storm is raging: repairing the blood-brain barrier in the fight against epilepsy","volume":"19","author":"Gorter","year":"2019","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.yebeh.2015.04.047","article-title":"Status epilepticus, blood-brain barrier disruption, inflammation, and epileptogenesis","volume":"49","author":"Gorter","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0085","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1528-1167.2011.03365.x","article-title":"The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy","volume":"53","author":"Gunthorpe","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2019.02.006","article-title":"Validating a model of benzodiazepine refractory nerve agent-induced status epilepticus by evaluating the anticonvulsant and neuroprotective effects of scopolamine, memantine, and phenobarbital","volume":"97","author":"Jackson","year":"2019","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0095","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3389\/fphar.2019.00560","article-title":"Enaminone modulators of extrasynaptic alpha4beta3delta gamma-aminobutyric acida receptors reverse electrographic status epilepticus in the rat after acute organophosphorus poisoning","volume":"10","author":"Johnstone","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0920-1211(02)00085-2","article-title":"Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus","volume":"50","author":"Jones","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0105","doi-asserted-by":"crossref","first-page":"8829","DOI":"10.1523\/JNEUROSCI.5176-14.2015","article-title":"Potent KCNQ2\/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitus","volume":"35","author":"Kalappa","year":"2015","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.emc.2014.09.010","article-title":"Organophosphate and carbamate poisoning","volume":"33","author":"King","year":"2015","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0115","doi-asserted-by":"crossref","first-page":"4946","DOI":"10.1111\/bph.13262","article-title":"delta Subunit-containing GABAA receptors are preferred targets for the centrally acting analgesic flupirtine","volume":"172","author":"Klinger","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0120","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/j.1476-5381.2011.01821.x","article-title":"Concomitant facilitation of GABAA receptors and KV7 channels by the non-opioid analgesic flupirtine","volume":"166","author":"Klinger","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0125","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1152\/jn.91062.2008","article-title":"A simple quantitative method for analyzing electrographic status epilepticus in rats","volume":"101","author":"Lehmkuhle","year":"2009","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0130","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1056\/NEJM199804023381407","article-title":"Status epilepticus","volume":"338","author":"Lowenstein","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0135","first-page":"381","article-title":"Neural lesions in the rat and their relationship to EEG delta activity following seizures induced by the nerve agent soman","volume":"19","author":"McDonough","year":"1998","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0140","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-7634(96)00050-4","article-title":"Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology","volume":"21","author":"McDonough","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/01480540903483417","article-title":"Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in guinea pigs","volume":"33","author":"McDonough","year":"2010","journal-title":"Drug Chem Toxicol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0150","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3389\/fneur.2019.00382","article-title":"The blood-brain barrier breakdown during acute phase of the pilocarpine model of epilepsy is dynamic and time-dependent","volume":"10","author":"Mendes","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2007.06.099","article-title":"Neuronal structures involved in the induction and propagation of seizures caused by nerve agents: implications for medical treatment","volume":"239","author":"Myhrer","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0160","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11064-007-9429-3","article-title":"Anticonvulsant efficacy of drugs with cholinergic and\/or glutamatergic antagonism microinfused into area tempestas of rats exposed to soman","volume":"33","author":"Myhrer","year":"2008","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0165","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neuro.2018.02.009","article-title":"Development of neuropathology following soman poisoning and medical countermeasures","volume":"65","author":"Myhrer","year":"2018","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0170","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nn1375","article-title":"Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior","volume":"8","author":"Peters","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0180","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1901\/jeab.1994.61-319","article-title":"Neurology and neuropathology of Soman-induced brain injury: an overview","volume":"61","author":"Petras","year":"1994","journal-title":"J Exp Anal Behav"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0185","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuro.2016.08.002","article-title":"A rodent model of human organophosphate exposure producing status epilepticus and neuropathology","volume":"56","author":"Pouliot","year":"2016","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0190","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0306-4522(99)00132-3","article-title":"N-methyl-D-aspartate receptor activation regulates refractoriness of status epilepticus to diazepam","volume":"93","author":"Rice","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0195","unstructured":"Robb EL, Baker MB. (2020) Organophosphate Toxicity StatPearls, Treasure Island (FL)."},{"key":"10.1016\/j.neuroscience.2021.03.029_b0200","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1124\/jpet.108.137794","article-title":"In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2\/Q3 (Kv7.2\/Kv7.3) activator in rodent anticonvulsant models","volume":"326","author":"Roeloffs","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0920-1211(95)00101-8","article-title":"D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures","volume":"23","author":"Rostock","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0210","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0006-8993(00)02513-0","article-title":"Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration","volume":"874","author":"Schmued","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0215","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1469-7793.2000.t01-2-00349.x","article-title":"Inhibition of KCNQ1-4 potassium channels expressed in mammalian cells via M1 muscarinic acetylcholine receptors","volume":"522","author":"Selyanko","year":"2000","journal-title":"J Physiol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0220","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1073\/pnas.0802805105","article-title":"Functional significance of axonal Kv7 channels in hippocampal pyramidal neurons","volume":"105","author":"Shah","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0225","first-page":"86","article-title":"Anticonvulsants for soman-induced seizure activity","volume":"6","author":"Shih","year":"1999","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0230","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1099-1263(199707)17:4<255::AID-JAT441>3.0.CO;2-D","article-title":"Neurochemical mechanisms in soman-induced seizures","volume":"17","author":"Shih","year":"1997","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0235","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12031-009-9253-0","article-title":"Protection against sarin-induced seizures in rats by direct brain microinjection of scopolamine, midazolam or MK-801","volume":"40","author":"Skovira","year":"2010","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0240","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.neuro.2012.03.006","article-title":"Neuropharmacological specificity of brain structures involved in soman-induced seizures","volume":"33","author":"Skovira","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0245","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/epi.16050","article-title":"Antiseizure and neuroprotective effects of delayed treatment with midazolam in a rodent model of organophosphate exposure","volume":"60","author":"Spampanato","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0250","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-2999(96)00073-8","article-title":"D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures","volume":"303","author":"Tober","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0255","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1528-1157.1994.tb02908.x","article-title":"Determinants of mortality in status epilepticus","volume":"35","author":"Towne","year":"1994","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0260","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/epi.12950","article-title":"The anticonvulsant retigabine is a subtype selective modulator of GABAA receptors","volume":"56","author":"Treven","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0265","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0014-2999(03)01426-2","article-title":"Synergy between retigabine and GABA in modulating the convulsant site of the GABAA receptor complex","volume":"464","author":"van Rijn","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0270","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1177\/0271678X19857818","article-title":"Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, \u201cM-type\u201d) K(+) currents in neurons","volume":"40","author":"Vigil","year":"2020","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0275","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-4886(88)90010-6","article-title":"Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam","volume":"101","author":"Walton","year":"1988","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0280","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jneumeth.2005.09.014","article-title":"Efficient unsupervised algorithms for the detection of seizures in continuous EEG recordings from rats after brain injury","volume":"152","author":"White","year":"2006","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0285","unstructured":"WHO, W.H.O. (2019) Suicide https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/suicide."},{"key":"10.1016\/j.neuroscience.2021.03.029_b0290","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/jpet.117.247106","article-title":"Midazolam-resistant seizures and brain injury after acute intoxication of diisopropylfluorophosphate, an organophosphate pesticide and surrogate for nerve agents","volume":"367","author":"Wu","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0295","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.119.264010","article-title":"Enhancing KCNQ channel activity improves neurobehavioral recovery after spinal cord injury","volume":"373","author":"Wu","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0300","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2006.06.007","article-title":"Sarin experiences in Japan: acute toxicity and long-term effects","volume":"249","author":"Yanagisawa","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0305","doi-asserted-by":"crossref","unstructured":"Yeung DT, Harper JR, Platoff GE Jr. (2020) The National Institutes of Health Chemical Countermeasures Research Program (NIH CCRP): A collaborative opportunity to develop effective and accessible chemical medical countermeasures for the American people. Drug Dev Res.","DOI":"10.1002\/ddr.21707"},{"key":"10.1016\/j.neuroscience.2021.03.029_b0310","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/acn3.497","article-title":"Flupirtine and diazepam combination terminates established status epilepticus: results in three rodent models","volume":"4","author":"Zhang","year":"2017","journal-title":"Ann Clin Transl Neurol"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452221001640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452221001640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:05:29Z","timestamp":1759680329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452221001640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":62,"alternative-id":["S0306452221001640"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2021.03.029","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Kv7 Modulator, Retigabine, is an Efficacious Antiseizure Drug for Delayed Treatment of Organophosphate-induced Status Epilepticus","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2021.03.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}